About Us

Integrated biotechnology R&D, production, storage, and sales

Company Profile

Kunzheng Biotechnology Co., Ltd. was founded in August 2019 and is located in the pharmaceutical and chemical industry park, Taiyangshan Development Zone, Wuzhong City, Ningxia Hui Autonomous Region. The company plans to invest a total investment of $88 million, covering an area of 50 acres, and invest in the construction of a project with an annual output of 3000 tons of L-carnitine and its salts and a project with an annual output of 5000 tons of fluorobenzene. The project was put into operation at the end of 2021.

It is estimated that the annual output value will be $88 million and more than 500 jobs will be solved. The production capacity of L-carnitine project will be the first in the world.

Kunzheng Biotech integrates high-end Biotechnology R & D, production, storage and sales. It is committed to developing into a high-end Biotechnology R & D, production and manufacturing base, constantly exploring the international market, and has entered the list of international product manufacturers and distributors. Its customers are mainly distributed in the United States, the European Union, India, Japan and other countries.

Kunzheng biology has completed ISO9001 (international quality management system certification), ISO14001 (international environmental management system certification) and is045001 (International Occupational Health and safety management system), strengthened the enterprise management level and improved the product quality; Kunzheng Biotech in the process of development will always adhere to the customer-centered service purpose, gather all kinds of resources of the company, strive to meet the diversified and personalized needs of customers, and wholeheartedly provide customers with high-quality products and customized services.

With the vision of "becoming an international high-end biotechnology strategic partner", Kunzheng Biotech shoulders the corporate mission of "being responsible to employees, enterprises and society", and strives to be a biotechnology leader in the United States.